Guests:

Dr. Stefan Irion is the Chief Scientific Officer of BlueRock Therapeutics and Dr. Viviane Tabar is the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center.  In this special episode, recorded in front of a live audience in New York, they talk about their work on BlueRock’s clinical trial for bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson’s disease. They also discuss what’s next for cell therapy and diversity in science and in patients.

Featured Products and Resources:

• Enter to win up to $500 USD towards your registration fee for a cell and gene therapy conference.
  

#footable_5807 {
font-family: inherit;
font-size: 14px;
}


#footable_parent_5807 thead
{
display: none;
}

#footable_parent_5807 a.nt_edit_link
{
display: none;
}

#footable_parent_5807 td
{
border-color: #fff;
}

#footable_parent_5807 img
{
margin-top: 0px;
}

.semantic_ui .ui.table
{
border: 0px solid !important;
}

.semantic_ui .ui.table td
{
padding: 0em;
}














#footable_5807 {
font-family: inherit;
font-size: 14px;
}


#footable_parent_5807 thead
{
display: none;
}

#footable_parent_5807 a.nt_edit_link
{
display: none;
}

#footable_parent_5807 td
{
border-color: #fff;
}

#footable_parent_5807 img
{
margin-top: 0px;
}

.semantic_ui .ui.table
{
border: 0px solid !important;
}

.semantic_ui .ui.table td
{
padding: 0em;
}

#footable_5808 {
font-family: inherit;
font-size: 14px;
}


thead
{
display: none;
}

#footable_parent_5808 a.nt_edit_link
{
display: none;
}

#footable_parent_5808 td
{
border-color: #fff;
}

#footable_parent_5808 img
{
margin-top: 0px;
}

.semantic_ui .ui.table
{
border: 0px solid !important;
}

.semantic_ui .ui.table td
{
padding: 0em;
}













Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe